We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$8.91M
Cap. Flow
+$5.42M
Cap. Flow %
3.95%
Top 10 Hldgs %
25.75%
Holding
1,127
New
41
Increased
160
Reduced
183
Closed
74

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.38M
2
BEAT
BioTelemetry, Inc.
BEAT
+$1.32M
3
RPM icon
RPM International
RPM
+$798K
4
DIS icon
Walt Disney
DIS
+$758K
5
COST icon
Costco
COST
+$641K

Top Sells

Rank Stock Value
1
IRBT
iRobot
IRBT
+$1.7M
2
MDSO
Medidata Solutions, Inc.
MDSO
+$958K
3
MSFT icon
Microsoft
MSFT
+$206K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$129K
5
AAPL icon
Apple
AAPL
+$111K

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Healthcare 15.28%
3 Financials 10.67%
4 Consumer Staples 7.75%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VAR
951
DELISTED
Varian Medical Systems, Inc.
VAR
$1K ﹤0.01%
8
– –
MIK
952
DELISTED
Michaels Stores, Inc
MIK
$1K ﹤0.01%
108
– –
BMCH
953
DELISTED
BMC Stock Holdings, Inc
BMCH
$1K ﹤0.01%
+49
New +$1.02K
MNK
954
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1K ﹤0.01%
61
– –
DLPH
955
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$1K ﹤0.01%
56
– –
PGNX
956
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1K ﹤0.01%
100
– –
WBC
957
DELISTED
WABCO HOLDINGS INC.
WBC
$1K ﹤0.01%
7
– –
AGN
958
DELISTED
Allergan plc
AGN
$1K ﹤0.01%
6
-101
-94% -$14K
LPT
959
DELISTED
Liberty Property Trust
LPT
$1K ﹤0.01%
26
– –
BT
960
DELISTED
BT Group plc (ADR)
BT
$1K ﹤0.01%
81
-2
-2% -$28
REP
961
DELISTED
REPSOL YPF SA ADS(RP 1 CAP SH)
REP
$1K ﹤0.01%
94
-47
-33% -$500
KNL
962
DELISTED
Knoll, Inc.
KNL
$1K ﹤0.01%
51
– –
VEDL
963
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$1K ﹤0.01%
133
-10
-7% -$98
CMO
964
DELISTED
Capstead Mortgage Corp.
CMO
$1K ﹤0.01%
115
– –
CHU
965
DELISTED
China Unicom (HONG KONG) Limited
CHU
$1K ﹤0.01%
+77
New +$883
EFII
966
DELISTED
Electronics for Imaging
EFII
$1K ﹤0.01%
24
– –
CADE
967
DELISTED
Cadence Bancorporation
CADE
$1K ﹤0.01%
33
– –
AEG icon
968
Aegon
AEG
$13.4B
– –
-908
Closed -$4K
AGEN
969
Agenus
AGEN
$258M
$0 ﹤0.01%
5
– –
AMRX icon
970
Amneal Pharmaceuticals
AMRX
$5.74B
– –
-67
Closed -$1K
AMT icon
971
American Tower
AMT
$76.7B
– –
-143
Closed -$28K
AMX icon
972
America Movil
AMX
$77.9B
– –
-50
Closed -$1K
EFOR
973
Everforth Inc
EFOR
$805M
– –
-29
Closed -$2K
BCC icon
974
Boise Cascade
BCC
$2.69B
– –
-58
Closed -$2K
BCS icon
975
Barclays
BCS
$93.3B
$0 ﹤0.01%
45
-56
-55% -$442
37 38
39
40 41

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
KNFPWM
Keeler & Nadler Financial Planning & Wealth Management Dublin, Ohio $295M AUM 18.48% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return

Front Row Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Front Row Advisors held 1,127 positions worth $137M, up 6.9% from $128M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Front Row Advisors deployed $5.42M of net new capital in Q2 2019, opening 41 new positions and adding to 160 existing holdings. Its largest new stake was BioTelemetry, Inc.: 25,089 shares worth $1.21M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $206K trimmed.

  • Front Row Advisors's largest Q2 2019 buy was BioTelemetry, Inc.: 25,089 shares worth $1.21M.
  • Front Row Advisors added most to Medtronic in Q2 2019, an estimated $2.38M increase.
  • Front Row Advisors's biggest Q2 2019 reduction was Microsoft, cutting an estimated $206K.
  • Front Row Advisors fully exited iRobot in Q2 2019, selling an estimated $1.7M.
  • Front Row Advisors's ten largest holdings make up 26% of its $137M portfolio in Q2 2019.
  • Front Row Advisors opened 41 new positions and closed 74 in Q2 2019.
  • Front Row Advisors's portfolio value rose 6.9% quarter-over-quarter to $137M.

Based on Front Row Advisors's 13F filing for Q2 2019, filed 27 Aug 2019.